Prior work suggests different interstitial lung diseases (ILDs) that share the radiological usual interstitial pneumonia (UIP) pattern have an overall worse prognosis. However, epidemiological data ...

The researchers reported, "The EUSTAR study revealed that a decline of over 10% in forced vital capacity (FVC) within one ...

Halo Biosciences ("Halo"), a clinical-stage biotechnology company developing extracellular matrix-targeted therapies, today ...

The following is a summary of “Influence of interstitial lung disease on systemic sclerosis hospitalizations, a national ...

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) can develop due to the immune system attacking the lungs. RA-ILD occurs in 5% to 10% of people with RA. Your lungs may already ...

Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...

Results presented at this year’s American Thoracic Society International Conference showed that the trials met their primary ...

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

Future Market Insights NEWARK, DE, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- The global progressive fibrosing interstitial lung disease (PF-ILD) treatment market is witnessing robust growth, ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...